Charles River ‘reaffirms’ commitment to tough neuroscience beat
Click here to view original web page at www.fiercebiotech.com Charles River Laboratories joins a host of biopharmas in helping boost academic neuroscience work. (Charles River) Neuroscience, and especially research into Alzheimer’s disease, has yielded nothing but failure from biopharma over the past 15 years. Now, CRO Charles River Laboratories has signed up to a consortium … Continue reading “Charles River ‘reaffirms’ commitment to tough neuroscience beat”